Medicare billing address
CMS Medicare provider billing file
4340 Clyo Rd Ste 200Dayton, OH 45459
CMS public data · NPI 1487630901
CMS public files list billing, prescribing, location, and participation fields for this NPI. Current plan networks, appointment availability, clinical outcomes, and patient-specific medical advice require separate verification.
CMS display name
Salma Akram, MD
Specialty
Credential
MD
NPI
1487630901
Primary source state
OH
Data retrieval date
July 28, 2026
Where these numbers come from, and what they cannot tell you
Public CMS records, 2024 reporting year. These are historical Medicare fields, not proof of current coverage, appointment availability, quality, or what someone will pay.
This page shows Medicare billing and Part D prescribing data for Salma Akram, MD from CMS public files. It covers 2024 claims data: services billed, the beneficiary panel, and the most-prescribed Part D drugs. It does not show current coverage, appointment availability, or quality ratings.
A licensed agent, not a call center
Peter Abilla, Licensed Medicare Insurance Sales Agent, NPN 22265186. Bring the doctors and prescriptions that matter to you, then check the details before you enroll.
Medicare participating
Yes
Individual assignment
Yes
Group assignment
Yes
CMS opt-out records
0
When CMS files list more than one address for the same NPI, each address stays tied to the CMS file that reported it.
CMS Medicare provider billing file
4340 Clyo Rd Ste 200CMS Doctors & Clinicians file
1 Wyoming StCMS Doctors & Clinicians file
4340 Clyo RdCMS Doctors & Clinicians file
5697 Shull RdIn the 2024 CMS provider billing file, this NPI had 470 Medicare beneficiaries and 13,493 total services. The average beneficiary age was 72, and the average HCC risk score was 1.3.
Total Medicare allowed amount
$362,849.19
Total Medicare payment amount
$285,592.27
Medicare beneficiaries
470
Total services
13,493
These percentages describe the Medicare beneficiary panel in the CMS utilization file. They are not a diagnosis for any individual patient and are not a quality score.
Hyperlipidemia
75%
CMS beneficiary-panel share
Hypertension
73%
CMS beneficiary-panel share
Diabetes
34%
CMS beneficiary-panel share
Mood disorders
32%
CMS beneficiary-panel share
Anxiety
30%
CMS beneficiary-panel share
Ischemic heart disease
29%
CMS beneficiary-panel share
Where these service numbers come from, and what they cannot tell you
Amounts shown are average Medicare-approved amounts per billed unit in CMS records. What a person pays depends on current coverage and cannot be read from this table alone.
| CMS service description | Services | Avg allowed |
|---|---|---|
| Injection, vedolizumab, intravenous, 1 mg | 7,501 | $21.84 |
| New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more | 119 | $164.48 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 111 | $71.87 |
| Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more | 90 | $124.42 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 76 | $249.19 |
| Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more | 70 | $88.33 |
| Biopsy of large bowel using a flexible endoscope | 69 | $121.29 |
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | 49 | $78.48 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 47 | $59.61 |
| Balloon dilation of esophagus, stomach, and/or upper small bowel using a flexible endoscope, less than 3.0 cm | 43 | $125.95 |
Where these Part D numbers come from, and what they cannot tell you
CMS data reports historical prescription drug events attributed to NPI 1487630901. Formularies, copays, prior authorization, and step therapy rules vary by current coverage.
| Rank | Drug | Generic name | Total claims | 30-day fills | Total drug cost |
|---|---|---|---|---|---|
| 1 | Omeprazole | Omeprazole | 857 | 1,885.3 | $7,854.46 |
| 2 | Famotidine | Famotidine | 619 | 1,386.8 | $5,046.79 |
| 3 | Pantoprazole Sodium | Pantoprazole Sodium | 299 | 718.2 | $3,100.82 |
| 4 | Ondansetron Hcl | Ondansetron Hcl | 207 | 214.2 | $2,195.73 |
| 5 | Sucralfate | Sucralfate | 133 | 182 | $2,644.35 |
| 6 | Gavilyte-G | Peg3350/Sod Sulf,Bicarb,Cl/Kcl | 106 | 106 | $1,396.80 |
| 7 | Dicyclomine Hcl | Dicyclomine Hcl | 105 | 147 | $2,354.12 |
| 8 | Esomeprazole Magnesium | Esomeprazole Magnesium | 61 | 115.2 | $1,102.50 |
| 9 | Promethazine Hcl | Promethazine Hcl | 57 | 67 | $360.56 |
| 10 | Metoclopramide Hcl | Metoclopramide Hcl | 44 | 50.6 | $375.83 |
CMS Part D records are historical aggregate claims data. They do not include current formulary status, pharmacy price, prior-authorization rules, network-directory status, or clinical-outcome data.
Graduation year
1991
Group/practice field
Premier Health Specialists Inc
Telehealth reported
Not reported
Verify plan-directory status, drug formulary rules, pharmacy pricing, appointment availability, and clinical questions against current plan documents and the relevant provider or care team.
The numbers above come from CMS public-use files for this NPI. Each link identifies the CMS release used and the retrieval date.